Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boston Sci Links With Guidewire Specialist In Pursuit Of 2015 FFR Launch

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific signed an agreement with the Japanese guidewire-maker Asahi Intecc to develop a fractional flow reserve wire that Boston seeks to launch as part of its first FFR system next year. Asahi will also provide components to upgrade Boston’s RotaWire atherectomy guidewire.

You may also be interested in...



Boston Sci Says It Will Be Careful About Resorbable Scaffold Investment

The company announced July 20 the start of its 30-patient, single-arm FAST study assessing its everolimus-eluting scaffold system, but executives says Boston Scientific will be closely considering whether the system warrants long-term investment, considering the promise of its Synergy stent.

Philips Increases Bet On Imaged-Guided Therapy With Volcano Buy

The imaging giant's $1.2 billion acquisition of intravascular assessment specialist Volcano deepens Philips' play in hospital cath labs and, Philips' CEO says in an interview, provides a combination of technology and know-how to create new catheter-based therapies for high-growth disease markets.

ESC 2014 Shines Spotlight On The Future Of Cardiology

The cardiology sector, long known as one of the most innovative in medtech, has a new wave of technologies on the horizon that could help reinvigorate the sector and create new multibillion-dollar market opportunities for device manufacturers. We take a closer look at these technologies, which include vagal nerve stimulation, remote monitoring for heart failure, as well as innovation in the percutaneous coronary intervention space, all of which were all in the spotlight at the recent European Society of Cardiology Congress 2014 in Barcelona.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT033249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel